ATTENTION SYRE SHAREHOLDERS: Investors who Lost Money on Spyre Therapeutics, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Spyre Therapeutics, Inc. (NASDAQ:SYRE) for potential violations of federal securities laws. The company disclosed that its financial statements for several periods should not be relied upon due to accounting errors.
January 24, 2025 | 6:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Spyre Therapeutics is under investigation for potential securities law violations after disclosing that its financial statements for several periods are unreliable due to accounting errors.
The investigation into Spyre Therapeutics for potential securities law violations and the unreliability of its financial statements are likely to negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100